Biologics in rheumatoid arthritis - recommendations for Swiss practice.

Details

Ressource 1Download: 21557111.pdf (200.65 [Ko])
State: Public
Version: Final published version
Serval ID
serval:BIB_1626948634BD
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Biologics in rheumatoid arthritis - recommendations for Swiss practice.
Journal
Swiss Medical Weekly
Author(s)
Dudler J., Möller B., Michel B.A., Villiger P.
ISSN
1424-3997 (Electronic)
ISSN-L
0036-7672
Publication state
Published
Issued date
2011
Volume
141
Pages
w13189
Language
english
Abstract
The new paradigm of therapy in rheumatoid arthritis is to aim toward early and complete remission, using a larger use of conventional DMARDs and biologic agents. The present recommendations were established through a consensus to help practitioners in their daily use of those agents, to reflect the current "best practice" in Switzerland.
Keywords
rheumatoid arthritis, biologics, anti-TNF, treatment optimisation, guidelines, CONTROLLED-TRIAL, DOUBLE-BLIND, COMBINATION THERAPY, METHOTREXATE, MULTICENTER, OUTCOMES, AGENT, ETANERCEPT, INHIBITION, RITUXIMAB
Pubmed
Web of science
Open Access
Yes
Create date
08/06/2011 10:10
Last modification date
20/08/2019 12:45
Usage data